Table IV.
Clinical outcomes of patients who responded and those who did not respond to metronomic chemotherapy.
| Outcomes | Responders | Non-responders | P-value |
|---|---|---|---|
| Response rate, % | 100 | 0 | |
| Clinical benefit rate, % | 100 | 47.1 | 0.0002 |
| Disease control rate, % | 100 | 58.8 | 0.0023 |
| Median TTF, months | 33 | 9 | 0.00002 |
| Median TTP, months | 41 | 11 | 0.000008 |
| Median OS, months | Not reached | 30 | 0.00002 |
| Median OS from MBC, months | Not reached | 40 | 0.0033 |
Bold print indicates statistical significance. TTF, time-to-treatment failure; TTP, time-to-progression; OS, overall survival; MBC, metastatic breast cancer.